FoxP3 + regulatory T cells (Tregs) can suppress antitumor immunity, and the ratio of CD8 + to FoxP3 + cells may be predictive for the clinical outcome of medullary breast cancer [39]. This evidence concerns the gene CD8A and medullary breast carcinoma.